AM
VC

Amgen

United Statesamgen.com

Amgen is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Oncology and Clinical Automation, 4 tracked investments.

4
Investments Tracked

About Amgen

Operating out of the United States, Amgen is a venture capital firm. Our dataset covers 4 investments involving Amgen.

Recorded deals span Healthcare & Life Sciences, Oncology, Clinical Automation and Mllt1 3 Inhibitors. Coverage extends to 8 sectors in total. Investments are concentrated at Series C+.

Amgen Ventures invests in early-stage biotech, therapeutics, and health tech companies. They focus on companies aligned with Amgen's therapeutic areas, such as oncology, inflammation, and metabolic disorders.

Investment Focus

Stage Focus
series-c-plus
Sectors
Healthcare & Life SciencesoncologyClinical Automationmllt1-3-inhibitorstargeted-protein-degradationacute-myeloid-leukemiacancer-therapyclinical-stage

Investment Thesis

Amgen Ventures invests in early-stage biotech, therapeutics, and health tech companies. They focus on companies aligned with Amgen's therapeutic areas, such as oncology, inflammation, and metabolic disorders.

Explore Amgen's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Oncology